Cogstate Limited (ASX:CGS)

Market Cap	234.60M
Revenue (ttm)	76.27M
Net Income (ttm)	11.87M
Shares Out	168.78M
EPS (ttm)	0.07
PE Ratio	20.25
Forward PE	21.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	121,405
Average Volume	102,196
Open	1.730
Previous Close	1.725
Day's Range	1.695 - 1.760
52-Week Range	0.795 - 1.760
Beta	-0.23
RSI	74.72
Earnings Date	Aug 22, 2025

About Cogstate

Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional ...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CGS

Financial Performance

In 2024, Cogstate's revenue was $43.43 million, an increase of 7.36% compared to the previous year's $40.45 million. Earnings were $5.45 million, an increase of 52.75%.

Financial numbers in USD